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Abstract The bioresorbable vascular stent (BVS) is
totally translucent and radiolucent, leading to challenges
when using conventional invasive imaging modalities.
Agreement between quantitative coronary angiography
(QCA), intravascular ultrasound (IVUS) and optical
coherence tomography (OCT) in the BVS is unknown.
Forty five patients enrolled in the ABSORB cohort B1
study underwent coronary angiography, IVUS and OCT
immediately post BVS implantation, and at 6 months.
OCT estimated stent length accurately compared to
nominal length (95% CI of the difference: -0.19; 0.37
and -0.15; 0.47 mm2 for baseline and 6 months,
respectively), whereas QCA incurred consistent under-
estimation of the same magnitude at both time points
(Pearson correlation = 0.806). IVUS yielded low accu-
racy (95% CI of the difference: 0.77; 3.74 and -1.15;
3.27 mm2 for baseline and 6 months, respectively),
with several outliers and random variability test–retest.
Minimal lumen area (MLA) decreased substantially
between baseline and 6 months on QCA and OCT and
only minimally on IVUS (95% CI: 0.11; 0.42). Agree-
ment between the different imaging modalities is
poor: worst agreement Videodensitometry-IVUS post-
implantation (ICCa 0.289); best agreement IVUS-OCT
at baseline (ICCa 0.767). All pairs deviated significantly
from linearity (P \ 0.01). Passing-Bablok non-para-
metric orthogonal regression showed constant and
proportional bias between IVUS and OCT. OCT is the
most accurate technique for measuring stent length,
whilst QCA incurs systematic underestimation (fore-
shortening) and solid state IVUS incurs random error.
Volumetric calculations using solid state IVUS are
therefore not reliable. There is poor agreement for MLA
estimation between all the imaging modalities studied,
including IVUS-OCT, hence their values are not
interchangeable.
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Introduction
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semi-crystalline poly-L-lactide (PLLA) backbone,
coated by a thin amorphous layer of poly-D,L-lactide
(PDLLA) containing the antiproliferative agent
everolimus. The device has enough radial strength
to counteract vascular recoil after angioplasty, while
the sustained elution of everolimus inhibits neointi-
mal hyperplasia. BVS struts are progressively
degraded by hydrolysis and fully resorbed 2 years
after implantation [1]. Two small platinum markers at
the proximal and distal edges ease fluoroscopic
visualization during deployment and angiographic
follow-up.
In contrast to metallic stents, the BVS is translu-
cent to optical radiation and totally radiolucent to
gamma radiation, with the only exception the radi-
opaque platinum markers at the edges. Therefore,
imaging the BVS with optical coherence tomography
(OCT) or quantitative coronary angiography (QCA)
requires a specific approach. In the case of QCA,
videodensitometry (VD) is particularly interesting
because the radiodensity of metallic stents leads to
overestimation of minimal lumen area (MLA) [2],
which the BVS can theoretically circumvent.
The BVS has been clinically tested in multi-
national studies involving highly specialized centres
[1, 3, 4] with multiple imaging techniques, including
intravascular ultrasound (IVUS) [1, 3–5], three-
dimensional QCA [5], multi-slice computed tomog-
raphy (MSCT) [5] and OCT [1, 3, 4]. Nevertheless, in
anticipation of the forthcoming widespread availabil-
ity of the BVS, comprehensive comparative studies
are needed for the correct interpretation of these
results. Recent studies have compared QCA with
MSCT immediately after stent deployment [5],
however they included neither IVUS or OCT, or the
comparison between VD and edge detection (ED).
Furthermore they also failed to provide any data on
the eventual influence of shrinkage or resorption on
the imaging parameters.
The present study compares different imaging
modalities in the BVS immediately after implantation
and at 6 months. This time point represents the
transition between the restoration phase (loss of
structural integrity, restoration of vascular reactivity)
and the resorption phase (loss of mass) of the device
[6]. Stent length and MLA were the parameters
chosen for the head-to-head comparison: the former
for being stable with time and known a priori, the
latter for being the most clinically relevant [7–9].
Methods
Study sample
The design of the ABSORB Cohort B study
(NCT00856856) has been previously described [4].
It enrolled patients with stable/unstable angina pec-
toris or silent ischemia, due to de novo coronary
lesions amenable for percutaneous treatment with the
BVS: diameter stenosis C50% and reference vessel
diameter 2.5–3.5 mm. Major exclusion criteria were:
acute myocardial infarction, unstable arrhythmias,
left ventricular ejection fraction B30%, restenotic
lesions, lesions located in the left main or in
bifurcations involving a side branch [2 mm, a
second clinically or hemodynamically significant
lesion in the target vessel, intracoronary thrombus,
or initial TIMI flow 0. The cohort was subdivided in
two groups: cohort B1 underwent multimodality
invasive imaging (QCA, IVUS, virtual histology,
palpography and OCT) at 6 and 24 months; whereas
cohort B2 underwent an identical imaging follow-up
protocol scheduled at 12 and 24 months. The avail-
ability of the different imaging modalities varied
depending on the sites. All the study lesions were
treated with the BVS revision 1.1 (3.0 9 18 mm).
The registry was approved by the ethics committee at
each participating institution and each patient gave
written informed consent before inclusion.
The present study compares the multi-imaging
results of cohort B1 (Fig. 1), post-implantation and at
6 months, analyzed in a core-lab setting (Cardialysis
BV, Rotterdam, The Netherlands).
Angiography and QCA analysis
Coronary arteriography was performed according to
standard procedures [10], using consecutive single-
plane orthogonal projections of the target lesion. QCA
was performed with the CAAS II system [11] (Pie
Medical BV, Maastricht, The Netherlands). The small
radiopaque markers at the ends of the stent helped
with the localisation of the radiolucent device for
definition of the in-stent segment. In-stent MLA by
VD was automatically calculated by the software
through densitometric analysis. In-stent MLA by ED
was calculated from the in-stent minimal lumen
diameter (MLD), which was provided by the software,
using the formula: MLA = 3.14 9 (MLD/2) [2].
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IVUS study
The stented segments were examined with phased
array solid state IVUS catheters (EagleEye; Volcano
Corporation, Rancho Cordova, CA, USA) with an
automated pullback at 0.5 mm/s. A region of
interest beginning 5 mm distal and extending
5 mm proximal to the stented segment was defined
for off-line analysis. Areas were measured with a
validated computer-based contour detection pro-
gramme (CURAD BV, Wijk bij Duurstede, The
Netherlands) that allows for semi-automatic detec-
tion of lumen, stent and vessel boundaries in
longitudinally reconstructed views of the region of
interest [12, 13].
OCT study
OCT pullbacks were obtained with M2, M3 or C7
systems (Lightlab Imaging, Westford, Massachu-
setts, USA), depending on the site, using the
occlusive [14] or non-occlusive technique [15], as
appropriate. Supplement table 1 provides detailed
technical specifications for each system. OCT cross-
sections were analysed offline at 1 mm longitudinal
intervals within the stented segment and 5 mm
proximal and distal to the stent edges, using
proprietary software (Lightlab Imaging, Westford,
Massachusetts, USA). Lumen contour was automat-
ically detected and manually edited if needed. OCT
in-stent MLA was defined as the minimal lumen
area in the segment between the distal and proximal
tips of the stent.
Statistical analysis
Descriptive statistics and Saphiro–Wilks test for
normality of the distribution were reported for each
variable. Means were compared with t test for paired
samples.
For MLA, agreement between methods was tested
by intraclass correlation coefficients (for absolute
agreement and consistency). Passing-Bablok non-
parametric orthogonal regression analysis was per-
formed in order to detect constant or proportional
biases between imaging modalities, using OCT
values in the y axis, since it has been validated in
vitro and in vivo for measurement of lumen area
[16, 17] and showed the best reproducibility of all the
methods hitherto [18–20]. Systematic constant or
proportional biases were defined as a constant or a
slope significantly different than 0 or 1 in the
orthogonal regression equation, respectively.
CUSUM test for deviation from linearity respect to
the orthogonal regression equation was performed,
and absolute agreement tested with Lin’s coefficient.
For stent length no proper analysis of agreement
between methods could be performed because all the
cases in the sample had the same objective measure-
ment (18 mm). Test–retest variability was assessed
graphically with a ‘‘target chart’’, correlating MLA
measurements post-implantation with those at
6 months follow-up, and drawing the corresponding
reference lines at 18 mm. The intersection of both
reference lines defines the centre of a target corre-
sponding to the methods measuring exactly 18 mm of
length at both time points.
Fig. 1 Case example illustrating the three imaging modalities compared in this study: quantitative coronary angiography (QCA),
phased array solid state intravascular ultrasound (IVUS) and optical coherence tomography (OCT)
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All the analyses and graphics were performed with
the PASW 17.0.2 statistical package (SPSS Inc.,
Chicago, IL, USA).
Results
Immediately post-stenting, QCA analysis was avail-
able in 45 patients, IVUS in 40, OCT in 29 and all the
imaging techniques together in 26 patients. At
6 months follow-up, QCA was available in 42, IVUS
in 40, OCT in 28 and the three techniques in 27
patients.
Table 1 shows the descriptive statistics of the stent
length measured by the different imaging modalities.
Figures 1 and 2 show the box-plot distribution and
the individual measurements, with a reference line at
18 mm (nominal length of the stent). QCA underes-
timates length, whilst OCT remains very close to the
nominal value, with very low variability. Solid state
IVUS shows the lowest accuracy for length measure-
ments, with wide dispersion and several outliers.
Table 2 shows the paired comparison of the means
for length measurement, as a chess table. QCA
significantly underestimates length compared to
IVUS, OCT and to the nominal length, post implant
(white squares) and at 6 months (orange squares). On
the contrary, IVUS overestimates length with respect
to OCT and the nominal value, only significantly at
baseline (Fig. 3).
Figure 4 shows the ‘‘target chart’’, depicting the
test–retest variability between post-implant and
6 months follow-up for stent length measurements.
QCA shows a typical systematic bias: variable
underestimation of length in the different cases, but
consistent underestimation of the same magnitude at
both time points (Pearson correlation = 0.806;
ICCa = 0.808; ICCc = 0.803), eventually due to
the effect of foreshortening on length measurements.
OCT proves reproducible accuracy, being close to the
nominal length at both time points, whilst IVUS
shows random variability, with an unpredictable
pattern.
Table 3 shows the descriptive statistics of the
in-stent MLA measured by the different imaging
modalities. Figure 5 shows the MLA box-plots. Both
QCA methods (ED and VD) have similar distribution,
and OCT provides the largest MLA at baseline. At
Table 1 Stent length measured by the different imaging modalities immediately post-stenting and at 6 months follow-up
Stent length (mm) n Mean Median SD P25 P75 Min Max Saphiro–Wilk
QCA Post 26 14.62 14.49 1.40 14.09 15.43 11.64 17.63 0.285
6m FU 27 15.01 14.69 1.60 13.86 16.18 12.67 17.81 0.153
IVUS Post 26 20.26 19.89 3.67 17.69 21.90 13.02 29.35 0.127
6m FU 27 19.06 19.14 5.59 17.29 20.82 7.99 34.20 0.060
OCT Post 26 18.10 18.15 0.65 17.82 18.37 16.05 19.36 0.107
6m FU 27 18.16 18.00 0.79 17.40 18.60 16.80 20.00 0.551
IVUS intravascular ultrasound, OCT optical coherence tomography, QCA quantitative coronary angiography, 6m FU 6 months
follow-up
Fig. 2 Box plot showing the length of the stent measured by
the different imaging modalities immediately post-implanta-
tion and at 6 months follow-up. The reference line represents
the nominal length of the device (18 mm). IVUS intravascular
ultrasound, OCT optical coherence tomography, QCA quanti-
tative coronary angiography, 6m FU 6 months follow-up
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6 months MLA decreases on ED, VD and OCT. In
contrast, IVUS MLA decreases to a lesser extent and
by 6-months becomes larger than OCT MLA. Indi-
vidual measurements of in-stent MLA (Fig. 6) show
very wide variability between different imaging
modalities within the same patient, with no clear
ranking as for the magnitude.
Table 4 shows the paired comparison of the means
for MLA, as a chess table. Both QCA methods (ED and
VD) significantly underestimate MLA compared to
IVUS and OCT at baseline (white cells) and at
6 months (orange cells). IVUS significantly underes-
timates MLA compared to OCT at baseline, but not at
6 months. The reason for this is that the reduction in
MLA between baseline and 6 months (yellow squares)
detected by IVUS (mean 0.26 mm2) is much less than
in any other imaging modality: 1/2 of that detected by
QCA (mean 0.66 mm2 for ED, 0.63 for VD) or 1/5 of
that detected by OCT (mean 1.24 mm2), (Fig. 6).
Table 5 shows the agreement between the different
imaging modalities for MLA. ED and VD have
moderate agreement at baseline (ICCa = 0.687) and
follow-up (ICCa = 0.568). Both QCA methods have
very poor agreement with either IVUS or OCT. IVUS
has good agreement with OCT at baseline (ICCa =
0.767) but only moderate at 6 months (ICCa = 0.684).
The low level of agreement between QCA and OCT
for in-stent MLA measurement prevents the reliable
detection of any type of bias in Passing-Bablok non-
parametric orthogonal regression (Table 6, Fig. 7).
Significant constant and proportional bias is detected
between ED and OCT at 6 months, due to a somewhat
better agreement between both methods (Lin’s coef-
ficient = 0.550). IVUS incurs a significant constant
and proportional bias respect to OCT (at baseline only
the constant is significant, but the slope is close to
reaching statistical significance: 95% CI 0.97; 1.49).
Discussion
Coronary stenting is one of those exceptional sce-
narios in biological sciences, in which a structure of
fixed and known size can be repeatedly measured
with different diagnostic tools and along different
time points. Stent length is known a priori and does
not change with time. This applies also to the BVS
device, with an additional peculiarity: all the ana-
lyzed stents have exactly the same nominal length
(18 mm). This rare situation precludes the application
of conventional statistical tests for the analysis of
agreement, which are initially conceived to test a
Table 2 Stent length measured by the different imaging modalities immediately post-stenting and at 6 months follow-up
Stent length (mm)
B
QCA IVUS OCT Nominal 
length 
(18mm)6m Post 6m Post 6m
A
QC
A P
os
t Mean diff (A-B) -0.04 -5.63 -4.35 -3.47 -3.49 -3.38
95% CI -0.46; 0.39 -7.25; -4.01 -6.26; -2.44 -4.03; -2.91 -4.10; -2.89 -3.94; -2.81
p-value 0.867 <0.001 <0.001 <0.001 <0.001 <0.001
6m
Mean diff (A-B) -4.90 -4.05 -3.21 -3.15 -2.99
95% CI -6.26; -3.53 -6.35; -1.75 -3.81; -2.61 -3.88; -2.43 -3.62; -2.35
p-value <0.001 0.001 <0.001 <0.001 <0.001
IV
U
S P
os
t Mean diff (A-B) 0.95 2.17 1.29 2.26
95% CI -0.88; 2.79 0.79; 3.54 -0.08; 2.65 0.77; 3.74
p-value 0.294 0.003 0.063 0.004
6m
Mean diff (A-B) 1.29 0.90 1.06
95% CI -1.22; 3.79 -1.37; 3.17 -1.15; 3.27
p-value 0.299 0.424 0.333
O
C
T P
os
t Mean diff (A-B) -0.30 0.09
95% CI -0.70; 0.10 -0.19; 0.37
p-value 0.131 0.508
6m
Mean diff (A-B) 0.16
95% CI -0.15; 0.47
p-value 0.289
‘‘Chess table’’ showing the paired comparison of the means: white cells for post-post; yellow cells for post-6m; orange cells for 6m–
6m comparisons
CI confidence interval, IVUS intravascular ultrasound, OCT optical coherence tomography, QCA quantitative coronary angiography,
6m 6 months follow-up
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linear relationship between two different methods
along a range of different values. Nevertheless, it is
an opportunity to extract unique information through
a different approach. Thus, the so called ‘‘target
chart’’ (Fig. 3) depicts the effect of foreshortening on
QCA length measurements, in a clear and illustrative
way, hereby described for the first time.
Likewise, we can understand graphically the
unpredictable random error of IVUS for length
measurement, although most of the time, stent length
is overestimated. Taking into account that a solid
state IVUS was employed in this study, the overes-
timation is most likely due to an irregular pullback
speed. The inaccuracy of solid state IVUS for length
measurements is a relevant finding, since it questions
the validity of any volumetric analysis performed by
this technique, as performed in several trials [21–23],
and is an additional argument to favour other
estimative parameters of neointimal hyperplasia
[24, 25].
OCT appears as a more accurate and reliable tool
for length measurements. Several reasons might
explain this extra accuracy compared to IVUS. First,
OCT is a rotational mechanical scanning system, with
the optical catheter pulled back within a sheath;
therefore there is less irregularity in the pullback
speed. Secondly, OCT systems have fast pullbacks
(up to 20 mm/s in the Fourier-domain systems) that
minimize the potential error due to cardiac structure
motion around the catheter. Finally, the metallic
markers at the stent edges, with a typical appearance
in the optical image, act as clear landmarks, improv-
ing the reproducibility of longitudinal measurements.
The findings regarding in-stent MLA are more
problematic to interpret. The first conclusion would
be that MLAs measured by the different methods are
neither equivalent, nor can they be reliably estimated
by any of the others. Even between QCA modalities
Fig. 3 Individual measurements of the stent length by the
different imaging modalities immediately post-implantation
and at 6 months follow-up. The reference line represents the
nominal length of the device (18 mm). BL baseline (immedi-
ately post-implantation), IVUS intravascular ultrasound, OCT
optical coherence tomography, QCA quantitative coronary
angiography
Fig. 4 ‘‘Target graphic’’ depicting the variability test–retest
of the different imaging modalities for the measurement of
stent length. Reference lines represent the nominal length of
the device (18 mm). IVUS intravascular ultrasound, OCT
optical coherence tomography, QCA quantitative coronary
angiography
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(ED vs. VD) or between intraluminal imaging tech-
niques (IVUS vs. OCT), no linear relation could be
defined. Although this conclusion might sound dis-
heartening, it is the expected result when methods of
very different accuracy are compared head-
to-head. Therefore, we can conclude that the different
imaging modalities in this study have substantial
Table 3 In-stent minimal lumen area measured by the different imaging modalities immediately post-stenting and at 6 months
follow-up
MLA (mm2) n Mean Median SD P25 P75 Min Max Saphiro–Wilk
QCA-ED Post 26 4.08 4.06 0.97 3.15 4.98 2.34 5.70 0.370
6m FU 27 3.61 3.68 1.02 2.65 4.68 1.76 5.07 0.107
QCA-VD Post 26 4.12 3.93 1.26 3.14 5.09 2.31 6.54 0.179
6m FU 27 3.73 3.73 1.23 2.71 4.48 1.76 6.63 0.669
IVUS Post 26 5.39 5.51 1.01 4.58 6.08 3.17 7.64 0.965
6m FU 27 5.11 5.29 0.94 4.21 5.71 3.06 6.66 0.236
OCT Post 26 5.97 6.01 1.21 4.97 7.05 3.10 7.78 0.366
6m FU 27 4.92 4.92 1.45 3.63 6.19 2.05 6.97 0.040
IVUS intravascular ultrasound, ED edge detection, MLA minimal lumen area, OCT optical coherence tomography, QCA quantitative
coronary angiography, VD videodensitometry, 6m FU 6 months follow-up
Fig. 5 Box plot showing the minimal lumen area (MLA) of
the stent measured by the different imaging modalities
immediately post-implantation and at 6 months follow-up.
ED edge detection, IVUS intravascular ultrasound, MLA
minimal lumen area, OCT optical coherence tomography,
QCA quantitative coronary angiography, VD videodensitome-
try, 6m FU 6 months follow-up
Fig. 6 Individual measurements of the minimal lumen area
(MLA) by the different imaging modalities immediately post-
implantation and at 6 months follow-up. ED edge detection,
IVUS intravascular ultrasound, MLA minimal lumen area, OCT
optical coherence tomography, QCA quantitative coronary
angiography, VD videodensitometry
Int J Cardiovasc Imaging (2012) 28:467–478 473
123
differences in their accuracy to estimate in-stent
MLA in the BVS, and thus their values are not
interchangeable. The chart in Fig. 6 illustrates at first
glance these discrepancies, with no need of any
statistical testing. The question which arises, is
therefore which technique is the most accurate?
Although OCT has been validated in vitro and in vivo
for lumen measurements [16, 17], with proven high
reproducibility [18–20]. IVUS has also undergone a
similar extensive validation process [26–28].
Table 4 In-stent minimal lumen area measured by the different imaging modalities immediately post-stenting and at 6 months
follow-up
B 
QCA-ED QCA-VD IVUS OCT In-stent MLA (mm2)
6m Post 6m Post 6m Post 6m 
Mean diff (A-B) 0.66 -0.04 0.53 -1.31 -1.02 -1.88 -0.64 
95% CI 0.39; 0.93 -0.40; 0.33 0.06; 0.99 -1.61; -1.02 -1.28; -0.76 -2.19; -1.58 -1.05; -0.24
Po
st
 
p-value <0.001 0.835 0.027 <0.001 <0.001 <0.001 0.003 
Mean diff (A-B) -0.81 -1.13 -1.98 -1.50 -2.50 -1.31 
95% CI -1.22; -0.40 -0.54; 0.29 -2.31; -1.65 -1.83; -1.18 -2.87; -2.13 -1.59; -1.04QC
A-
ED
 
6m
 
p-value <0.001 0.544 <0.001 <0.001 <0.001 <0.001 
Mean diff (A-B) 0.63 -1.28 -0.92 -1.85 -0.50 
95% CI 0.32; 0.94 -1.71; -0.84 -1.32; -0.51 -2.26; -1.44 -1.06; -0.06
Po
st
 
p-value <0.001 <0.001 <0.001 <0.001 0.079 
Mean diff (A-B) -1.83 -1.38 -2.38 -1.19 
95% CI -2.29; -1.36 -1.80; -0.95 -2.89; -1.88 -1.74; -0.63QC
A-
VD
 
6m
 
p-value <0.001 <0.001 <0.001 <0.001 
Mean diff (A-B) 0.26 -0.57 0.68 
95% CI 0.11; 0.42 -0.81; -0.34 0.27; 1.08 
Po
st
 
p-value 0.002 <0.001 0.002 
Mean diff (A-B) -0.89 0.19 
95% CI -1.23; -0.61 -0.19; 0.57 
IV
U
S 
6m
 
p-value <0.001 0.320 
Mean diff (A-B) 1.24 
95% CI 0.88; 1.61 
A
O
C
T
Po
st
 
p-value <0.001 
‘‘Chess table’’ showing the paired comparison of the means: white cells for post–post; yellow cells for post-6m; orange cells for
6m–6m comparisons
CI confidence interval, ED edge detection, IVUS intravascular ultrasound, MLA minimal lumen area, OCT optical coherence
tomography, QCA quantitative coronary angiography, VD videodensitometry, 6m FU 6 months follow-up
Table 5 Concordance between different imaging modalities for in-stent minimal lumen area
MLA (mm2) VD IVUS OCT
Post-implant (n = 26) ED ICCa 0.687 (0.411, 0.847) 0.391 (-0.097, 0.748) 0.310 (-0.064, 0.694)
ICCc 0.679 (0.402, 0.842) 0.731 (0.485, 0.870) 0.765 (0.542, 0.887)
VD ICCa 0.343 (-0.097; 0.672) 0.315 (-0.096, 0.681)
ICCc 0.551 (0.215, 0.770) 0.665 (0.380, 0.834)
IVUS ICCa 0.767 (0.184, 0.919)
ICCc 0.864 (0.719, 0.936)
6 months (n = 27) ED ICCa 0.568 (0.245, 0.777) 0.300 (-0.095, 0.664) 0.549 (-0.088, 0.850)
ICCc 0.562 (0.238, 0.773) 0.648 (0.361, 0.822) 0.848 (0.694, 0.928)
VD ICCa 0.289 (-0.103, 0.623) 0.329 (-0.050, 0.629)
ICCc 0.512 (0.171, 0.744) 0.450 (0.091, 0.705)
IVUS ICCa 0.684 (0.421, 0.842)
ICCc 0.684 (0.417, 0.843)
All values are significant at a level of P \ 0.01
CI confidence interval, ED edge detection, ICCa intraclass correlation coefficient for absolute agreement, ICCc intraclass
correlation coefficient for consistency, IVUS intravascular ultrasound, MLA minimal lumen area, OCT optical coherence tomography,
QCA quantitative coronary angiography, VD videodensitometry
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Unfortunately the current study design does not help
in answering this question.
In this study in-stent MLA immediately post-
stenting was larger when measured by OCT
compared with IVUS. This is at variance with
other comparative publications in non-stented ves-
sels where IVUS areas were systematically larger
than those measured by OCT, using occlusive or
non-occlusive techniques [16, 17, 20]. At 6 months
follow-up, however, IVUS MLA, was slightly but
non-significantly larger than OCT MLA, which is
more consistent with the published literature. This
might be specific to the BVS, due to its particular
design and optical properties that enable OCT to
accurately measure the lumen area in the inter-
struts spaces, enlarging substantially the OCT
lumen areas after implant. Conversely, IVUS sig-
nals are very sensitive to artefact induced by the
stent, and hence the lumen contour usually follows
the adluminal side of the struts, neglecting the
inter-struts spaces, and thus underestimating lumen
areas with respect to OCT at baseline. At 6 months
follow-up the inter-strut spaces have been inte-
grated in the neointimal layer and both OCT and
IVUS draw the lumen contour inside the adluminal
side of the stent struts. This might explain why the
reduction in MLA is maximal in OCT whilst
minimal in IVUS.
ED and VD yield similar MLA values in scenarios
where the circular shape of the vessel is preserved or
restored, like immediately after stenting [29], and
more dissimilar values in scenarios where the lumen
symmetry is altered, like after atherectomy [30] or
after plain balloon angioplasty [29, 31]. In this study,
no significant difference between ED and VD MLA
was detected either at baseline or at 6 months,
suggesting that the circular shape of the vessel is
preserved at both time points, in contrast to the
findings on BVS revision 1.0 [1]. The device tested in
this study is the BVS revision 1.1., which has
improved mechanical properties which have been
achieved by altering the crystallization process of the
polymer, and through some changes to the device
design that reduce the maximal circular unsupported
stent area [32]. Improved mechanical radial support
could result in less shrinkage, with better preservation
of luminal symmetry, and thus explain the lack of
significant differences between ED and VD MLA. In
prior studies VD correlated better and yielded closer
values to IVUS than ED [33, 34]. This is not observed
in the present study, suggesting that additional factors
other than the preservation of regular luminal geom-
etry might also be playing a role.
Limitations
The reduced sample size is a limiting factor in this
study. A larger sample size might have permitted a
more accurate description of some of the bias detected
between techniques.
All the implanted devices in this cohort had the same
nominal length (18 mm) and diameter (3 mm).
Table 6 Concordance between different imaging modalities for in-stent minimal lumen area immediately post-implantation and at
6 months follow-up: results of Passing-Bablok non-parametric orthogonal regression
MLA (mm2) Y = OCT
Constant 95% CI Slope 95% CI Discordance Lin’s coefficient
(absolute agreement)
Lower Upper Lower Upper
Post X= QCA-ED 0.31 -1.19 1.70 1.28 0.89 1.69 NS 0.325
QCA VD 2.33 0.74 3.08 0.94 0.67 1.51 Constant 0.306
IVUS -1.19 -2.34 -0.23 1.20 0.97 1.49 Constant 0.764
6m X= QCA-ED -1.16 -2.07 -0.32 1.37 1.15 1.60 Const & prop 0.550
QCA VD 0.92 -1.75 2.92 1.32 0.78 2.04 NS 0.330
IVUS -2.53 -6.26 -0.82 1.51 1.20 2.18 Const & prop 0.676
CUSUM test for deviation of normality \0.01 in all cases
CI confidence interval, ED edge detection, IVUS intravascular ultrasound, MLA minimal lumen area, OCT optical coherence
tomography, QCA quantitative coronary angiography, VD videodensitometry, 6m 6 months follow-up, NS non-significant, Const &
prop constant and proportional
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Additional comparative studies including different
stent lengths will be required to better understand the
accuracy of the imaging modalities for length mea-
surement, since the present analysis is limited in this
respect.
Likewise, the linear relations between different
diagnostic tests regarding MLA can become unstable
when all the measurements are in a narrow range, as it
is the case. Further studies including different stent
diameters might eventually result in better agreement
between the same imaging modalities with respect to
MLA.
The poor results found with IVUS might be
partially explained by the use of a solid state system.
The agreement between IVUS and OCT for length
measurement is likely to improve using a mechanical
sheath-based scanning system with a more regular
pullback speed.
31% of the OCT studies at baseline and 18% at
6 months were acquired using the occlusive tech-
nique. This is a limitation of the study, since the
occlusive technique provides lower areas and vol-
umes than the non-occlusive one [17]. Nevertheless,
in the charts comparing individual measurements this
Fig. 7 Passing-Bablok
non-parametric orthogonal
regression of minimal
lumen area (MLA)
measured by the different
imaging modalities (x axis)
and that measured by
optical coherence
tomography (y axis). Data
immediately post-
implantation and at
6 months follow-up.
ED edge detection, IVUS
intravascular ultrasound,
MLA minimal lumen area,
OCT optical coherence
tomography,
QCA quantitative coronary
angiography,
VD videodensitometry
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fact did not seem to significantly influence the MLA
results.
Conclusions
OCT is the most accurate method to measure BVS
length immediately post-implantation and at
6 months follow-up, whilst QCA incurs systematic
underestimation and solid state IVUS incurs random
error. There is very poor agreement between QCA,
IVUS and OCT for the estimation of in-stent MLA,
and no linear relation between any of the methods
could be demonstrated.
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